Thalassemia in Laos: Situation Analysis by Dr. Sourideth Sengchanh, Dr. Alongkone Phengsavanh, Assoc. Prof. Dr. Khampe Phongsavat, University of Health Sciences, Vientiane, Laos. Presented by Assoc. Prof. Dr. Khampe Phongsavat.
Kolkata Call Girls Shobhabazar đŻCall Us đ 8005736733 đ đ Top Class Call Gir...
Â
Republic of Laos - Current Situation in Control Strategies and Health Systems in Asia
1. Thalassemia in Laos:Â
Thalassemia in Laos:
Situation analysis
y
Dr. Sourideth Sengchanh
id h h h
Dr. Alongkone Phengsavanh
Assoc. Prof. Dr. Khampe Phongsavat
p g
University of Health Sciences, Vientiane , Laos
2. Country profile
Country profile
⢠P
Population of 5,621,000Â
l ti f 5 621 000
⢠Laos is also very ethnicallyÂ
diverse, and socioâcultural beliefsÂ
,
and practices among the 49Â
ethnic groups.
⢠Laos is having geographic and
Laos is having geographic andÂ
financial barriers and relativelyÂ
poor health infrastructure.
⢠Laos has experienced relativelyÂ
high economic growth in the lastÂ
decade
⢠Total budget on health is lessÂ
than 10%
⢠Annual birth rate
Annual birth rate
⢠Average income
3. Health system in Laos
Health system in Laos
⢠Health services system in Laos is divided into 3Â
levels:
â Primary care : Health centers and district hospitals
y p
â Secondary care: Provincial and regional hospitals
â Tertiary care: Central and University hospitals
Tertiary care: Central and University hospitals
⢠No private hospital, only private clinic are runÂ
by government staffs after working hours.
by government staffs after working hours
⢠Nonâcommunicable diseases national strategyÂ
is being developed
i b i d l d
⢠No special policy on Hb diseases.
p p y
8. Barriers of thalassemia control in Laos
Barriers of thalassemia control in Laos
â Policy of thalassemia control is not available
â National guideline for thalassemia screening andÂ
treatment is not unified
â Lacking of human resources such as hematologist
Lacking of human resources  such as hematologistÂ
, laboratory technicians, etc
â Lacking of medical equipment in the field of
Lacking of medical equipment in the field ofÂ
hematology
â Iron chelators are not included in the essential
Iron chelators are not included in the essentialÂ
drug list
â Thalassemia treatment unit is not available
9. The way forwards
The way forwards
⢠Development of national strategic planning forÂ
p
thalassemia treatment and prevention
⢠Development of update national treatmentÂ
guidelines for thalassemia
guidelines for thalassemia
⢠Initiation of national thalassemia screeningÂ
program
⢠Development of community and hospital
Development of community and hospitalÂ
based registration system for thalassemia.
10. The way forwards
y
⢠Inclusion of iron chelators into national
Inclusion of iron chelators into nationalÂ
essential drug list
⢠I
Increasing the public  awareness andÂ
i th bli d
community motivation regarding the costÂ
effectiveness for thalassemia prevention andÂ
treatment
⢠Organize the thalassemia prevention campaign
⢠Collaborate internationally in term of researchÂ